AM2233 – 5 mg

Brand:
Cayman
CAS:
444912-75-8
Storage:
-20
UN-No:
Non-Hazardous - 2811 / 6.1

AM2233 is a full agonist of the central cannabinoid (CB1) receptor (Ki = 2.8 nM).{20115} Most of the affinity towards the CB1 receptor resides within the (R)-enantiomer of AM2233, which exhibits a Ki value of 0.2 nM and has ~8-fold higher affinity for CB1 compared to WIN 55,212-2 (Ki = 1.6 nM).{20115} AM2233 was developed for use as a selective radioligand for mapping the distribution of the CB1 receptor in the brain.{20115} Recently, however, AM2233 has received attention as a cannabimimetic acquired for recreational use as a “legal high” replacement for restricted substances. This compound is intended for forensic and research applications.  

 

Available on backorder

SKU: 11008 - 5 mg Category:

Description

A full agonist of the CB1 receptor (Ki = 2.8 nM); the (R)-enantiomer exhibits a Ki value of 0.2 nM and has ~8-fold higher affinity for CB1 compared to WIN 55,212-2 (Ki = 1.6 nM); intended for forensic applications


Formal name: (2-iodophenyl)[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-methanone

Synonyms: 

Molecular weight: 458.3

CAS: 444912-75-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Drugs of Abuse||Research Area|Forensic Chemistry & Toxicology|Cannabinoids|Synthetic Cannabinoids